You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Biocatalytic Polymer Skin Adhesives

    SBC: AGENTASE LLC            Topic: N/A

    This Phase II STTR proposal describes the development of a prototype enzyme-containing adhesive capable of attaching biocatalytic activity directly to skin. The adhesive, when containing organophosphorus-hydrolyzing enzymes, shall serve to protectunderlying skin from otherwise toxic applications of nerve agents and pesticides. Agentase, a recognized world leader in developing polymer-based carri ...

    STTR Phase II 2001 Department of DefenseArmy
  2. 3D Woven Composites for New and Innovative Impact and Penetration Resistant Systems (MSC P1T05-114)

    SBC: MATERIALS SCIENCES LLC            Topic: N/A

    The objective of the work proposed herein is to develop innovative methodologies and techniques for the use of 3D woven composites with enhanced structural and ballistic characteristics for wide ranges of armor and structural applications. A family of 3Dintegrally woven composites, which utilizes multi-axial weave designs, have been examined and analyzed in the Phase I study. These innovative 3D ...

    STTR Phase II 2001 Department of DefenseArmy
  3. Long Circulating Liposomal Camptothecins CAP and EAP

    SBC: TIGEN PHARMACEUTICALS            Topic: N/A

    DESCRIPTION (provided by applicant): Based on the extensive data generated during the phase I portion of our studies, there is sufficient and compelling information to support the further development of the highly lipophilic and blood-stable topoisomerase inhibitor, DB-67. In part, the pre-clinical and clinical evaluation of DB-67 is currently being supported by ...

    STTR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health
  4. Nonlinear Reduced Order Modeling of Limit Cycle Oscillations of Aircraft Wiings

    SBC: ZONA TECHNOLOGY INC            Topic: N/A

    The Zona technology/Duke University team process a challenging set of tasks to be accomplished in two years time that builds upon the very substantial progress already made in Phase I. Specifically, the 2D, Euler Euations CFD model (developed in Phase I)that uses a harmonic balance solution technique will be extended to include teh effects of viscosity (Navier-Stoke equations)and multiple structu ...

    STTR Phase II 2001 Department of DefenseAir Force
  5. Novel Antimicrobial Agents Targeting Drug Resistant Bacterial Biofilms

    SBC: Enantigen Therapeutics            Topic: A09AT004

    This project builds on patterns derived from natural antimicrobial peptide sequences to develop novel compounds with better systemic activity, lower cytotoxicity and broader spectrum activity against multidrug resistant (MDR) pathogens. In Phase I and the

    STTR Phase II 2012 Department of DefenseArmy
  6. Deep ultraviolet laser for Raman spectroscopy

    SBC: TIPD LLC            Topic: A11aT005

    The Phase II program proposes to commercialize frequency quadrupling technology developed in the College of Optical Sciences at the University of Arizona to build a 244 nm UV frequency quadrupled optically pumped semiconductor laser (FQ-OPSL). The laser will provide a self-contained small footprint (

    STTR Phase II 2012 Department of DefenseArmy
  7. Fine Scale Modeling and Forecasts of Upper Atmospheric Turbulence for Operational Use

    SBC: IntelliWare LLC            Topic: AF09BT27

    ABSTRACT: The objective of this STTR Phase II project is to continue the development of a fine scale forecast model capability that will provide a technologically superior, high resolution atmospheric decision tool to accurately predict areas of clear air turbulence in the upper troposphere and lower stratosphere (UTLS). Accurate real time knowledge of the dynamics in the UTLS is critical to supp ...

    STTR Phase II 2012 Department of DefenseAir Force
  8. A novel vaccine: botulinum neurotoxin subunit on a viral carrier.

    SBC: MOLECULAR TARGETING TECHNOLOGIES, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): According to the NIAID fact sheet on Botulism, the extreme toxicity of botulinum neurotoxins (BoNT) and the ease of production, transport, and delivery make this an agent of extreme bioterrorism concern. Nonetheless, although there are major vaccine development initiatives ongoing, there currently is no approved Botulinum toxin vaccine available. Advances i ...

    STTR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  9. ALEXSA Standardization for Clinical Use

    SBC: ASSESSMENTS ILLUSTRATED            Topic: NIDA

    DESCRIPTION (provided by applicant): This STTR Phase II application is to finalize the one-of-its-kind Assessment of Liability and Exposure to Substance use and antisocial behavior(c) (ALEXSA(c)) for educator, pediatric, prevention and epidemiology uses. The ALEXSA system, first funded by a NIDA K-Award, acquires child-report (8- to 13-year-olds) data using an illustrated, computer format that is ...

    STTR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  10. Delivery of Polyphenols in Gum for Treatment of Gingivitis

    SBC: FOUR TIGERS, LLC            Topic: NIDCR

    DESCRIPTION (provided by applicant): Periodontitis represents a polymicrobial disease, in which a complex microbial ecology that matures in biofilms in the subgingival sulcus triggers a chronic immune-inflammatory lesion that destroys soft and hard tissues of the periodontium. Despite the great improvement in oral health in recent years, gingivitis and periodontal disease remain prominent and aff ...

    STTR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government